- Home
- GPUS vs NLSP Comparison
GPUS vs NLSP Comparison
Compare GPUS & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPUS
- NLSP
- Stock Information
- Founded
- GPUS 1969
- NLSP 2015
- Country
- GPUS United States
- NLSP Switzerland
- Employees
- GPUS N/A
- NLSP N/A
- Industry
- GPUS
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- GPUS
- NLSP Health Care
- Exchange
- GPUS NYSE
- NLSP Nasdaq
- Market Cap
- GPUS 7.6M
- NLSP 6.2M
- IPO Year
- GPUS 1996
- NLSP 2021
- Fundamental
- Price
- GPUS $4.70
- NLSP $1.91
- Analyst Decision
- GPUS
- NLSP
- Analyst Count
- GPUS 0
- NLSP 0
- Target Price
- GPUS N/A
- NLSP N/A
- AVG Volume (30 Days)
- GPUS 89.9K
- NLSP 2.2M
- Earning Date
- GPUS 11-19-2024
- NLSP 10-18-2024
- Dividend Yield
- GPUS N/A
- NLSP N/A
- EPS Growth
- GPUS N/A
- NLSP N/A
- EPS
- GPUS N/A
- NLSP N/A
- Revenue
- GPUS $139,425,000.00
- NLSP N/A
- Revenue This Year
- GPUS N/A
- NLSP N/A
- Revenue Next Year
- GPUS N/A
- NLSP N/A
- P/E Ratio
- GPUS N/A
- NLSP N/A
- Revenue Growth
- GPUS 3.50
- NLSP N/A
- 52 Week Low
- GPUS $3.09
- NLSP $1.73
- 52 Week High
- GPUS $44.43
- NLSP $20.80
- Technical
- Relative Strength Index (RSI)
- GPUS N/A
- NLSP 41.47
- Support Level
- GPUS N/A
- NLSP $1.87
- Resistance Level
- GPUS N/A
- NLSP $2.08
- Average True Range (ATR)
- GPUS 0.00
- NLSP 0.27
- MACD
- GPUS 0.00
- NLSP 0.03
- Stochastic Oscillator
- GPUS 0.00
- NLSP 8.77
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.